Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05731856Not ApplicableRecruiting

Impact of Heart Rate Variability Modulation on Stress Management Among Physicians

Role: collaborator

NCT05260489Withdrawn

Apollo Remote Observational Sleep Study

Role: lead

NCT04983342Not ApplicableCompleted

Apollo Device for Metastatic Breast Cancer (MBC)

Role: collaborator

NCT06097442Unknown

Effect of Apollo Wearable on Long COVID-19 Symptoms.

Role: collaborator

NCT05274230Not ApplicableUnknown

Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy

Role: lead

All 5 trials loaded